Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 83.61 percent increase over losses of $(1.22) per share from the same period last year.
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 83.61 percent increase over losses of $(1.22) per share from the same period last year.
Comments